318 related articles for article (PubMed ID: 23980919)
1. Correlation of headache frequency and psychosocial impairment in migraine: a cross-sectional study.
Ruscheweyh R; Müller M; Blum B; Straube A
Headache; 2014 May; 54(5):861-71. PubMed ID: 23980919
[TBL] [Abstract][Full Text] [Related]
2. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
3. Pain beliefs and perceptions inventory: a cross-sectional study in chronic and episodic migraine.
Condello C; Piano V; Dadam D; Pinessi L; Lantéri-Minet M
Headache; 2015 Jan; 55(1):136-48. PubMed ID: 25545038
[TBL] [Abstract][Full Text] [Related]
4. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
[TBL] [Abstract][Full Text] [Related]
5. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
6. Opioid use and dependence among persons with migraine: results of the AMPP study.
Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
[TBL] [Abstract][Full Text] [Related]
7. Depression and anxiety: effect on the migraine-obesity relationship.
Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program.
Wallasch TM; Angeli A; Kropp P
Headache; 2012; 52(7):1094-105. PubMed ID: 22703374
[TBL] [Abstract][Full Text] [Related]
9. Predicting disability and quality of life in a community-based sample of women with migraine headache.
Kolotylo CJ; Broome ME
Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
[TBL] [Abstract][Full Text] [Related]
10. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
11. Negative impact of episodic migraine on a university population: quality of life, functional impairment, and comorbid psychiatric symptoms.
Smitherman TA; McDermott MJ; Buchanan EM
Headache; 2011 Apr; 51(4):581-9. PubMed ID: 21457242
[TBL] [Abstract][Full Text] [Related]
12. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Buse DC; Serrano D; Holland S; Reed ML
Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
[TBL] [Abstract][Full Text] [Related]
13. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
15. Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study.
D'Amico D; Grazzi L; Bussone G; Curone M; Di Fiore P; Usai S; Leonardi M; Giovannetti AM; Schiavolin S; Raggi A
Headache; 2015 May; 55(5):636-45. PubMed ID: 25913219
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbance and affective comorbidity among episodic migraineurs.
Walters AB; Hamer JD; Smitherman TA
Headache; 2014 Jan; 54(1):116-24. PubMed ID: 23808359
[TBL] [Abstract][Full Text] [Related]
17. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
18. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with burden of primary headache in a specialty clinic.
Cassidy EM; Tomkins E; Hardiman O; O'Keane V
Headache; 2003 Jun; 43(6):638-44. PubMed ID: 12786924
[TBL] [Abstract][Full Text] [Related]
20. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]